These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37023937)

  • 1. PolyQ length-dependent metabolic alterations and DNA damage drive human astrocyte dysfunction in Huntington's disease.
    Lange J; Gillham O; Flower M; Ging H; Eaton S; Kapadia S; Neueder A; Duchen MR; Ferretti P; Tabrizi SJ
    Prog Neurobiol; 2023 Jun; 225():102448. PubMed ID: 37023937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte molecular signatures in Huntington's disease.
    Diaz-Castro B; Gangwani MR; Yu X; Coppola G; Khakh BS
    Sci Transl Med; 2019 Oct; 11(514):. PubMed ID: 31619545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin accessibility and transcription dynamics during in vitro astrocyte differentiation of Huntington's Disease Monkey pluripotent stem cells.
    Goodnight AV; Kremsky I; Khampang S; Jung YH; Billingsley JM; Bosinger SE; Corces VG; Chan AWS
    Epigenetics Chromatin; 2019 Nov; 12(1):67. PubMed ID: 31722751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
    van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
    BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
    Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
    PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington's Disease.
    Wetzel R
    Acc Chem Res; 2020 Oct; 53(10):2347-2357. PubMed ID: 32975927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems Genetic Analyses Highlight a TGFβ-FOXO3 Dependent Striatal Astrocyte Network Conserved across Species and Associated with Stress, Sleep, and Huntington's Disease.
    Scarpa JR; Jiang P; Losic B; Readhead B; Gao VD; Dudley JT; Vitaterna MH; Turek FW; Kasarskis A
    PLoS Genet; 2016 Jul; 12(7):e1006137. PubMed ID: 27390852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
    Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
    Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunctional Calcium and Glutamate Signaling in Striatal Astrocytes from Huntington's Disease Model Mice.
    Jiang R; Diaz-Castro B; Looger LL; Khakh BS
    J Neurosci; 2016 Mar; 36(12):3453-70. PubMed ID: 27013675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte transduction is required for rescue of behavioral phenotypes in the YAC128 mouse model with AAV-RNAi mediated HTT lowering therapeutics.
    Stanek LM; Bu J; Shihabuddin LS
    Neurobiol Dis; 2019 Sep; 129():29-37. PubMed ID: 31042572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive astrocytes promote proteostasis in Huntington's disease through the JAK2-STAT3 pathway.
    Abjean L; Ben Haim L; Riquelme-Perez M; Gipchtein P; Derbois C; Palomares MA; Petit F; Hérard AS; Gaillard MC; Guillermier M; Gaudin-Guérif M; Aurégan G; Sagar N; Héry C; Dufour N; Robil N; Kabani M; Melki R; De la Grange P; Bemelmans AP; Bonvento G; Deleuze JF; Hantraye P; Flament J; Bonnet E; Brohard S; Olaso R; Brouillet E; Carrillo-de Sauvage MA; Escartin C
    Brain; 2023 Jan; 146(1):149-166. PubMed ID: 35298632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Models: HD Patient-Derived Pluripotent Stem Cells.
    Geater C; Hernandez S; Thompson L; Mattis VB
    Methods Mol Biol; 2018; 1780():41-73. PubMed ID: 29856014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart.
    Melkani GC; Trujillo AS; Ramos R; Bodmer R; Bernstein SI; Ocorr K
    PLoS Genet; 2013; 9(12):e1004024. PubMed ID: 24367279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactions.
    Boussicault L; Hérard AS; Calingasan N; Petit F; Malgorn C; Merienne N; Jan C; Gaillard MC; Lerchundi R; Barros LF; Escartin C; Delzescaux T; Mariani J; Hantraye P; Beal MF; Brouillet E; Véga C; Bonvento G
    J Cereb Blood Flow Metab; 2014 Sep; 34(9):1500-10. PubMed ID: 24938402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A huntingtin peptide inhibits polyQ-huntingtin associated defects.
    Arribat Y; Bonneaud N; Talmat-Amar Y; Layalle S; Parmentier ML; Maschat F
    PLoS One; 2013; 8(7):e68775. PubMed ID: 23861941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo.
    Zhang X; Smith DL; Meriin AB; Engemann S; Russel DE; Roark M; Washington SL; Maxwell MM; Marsh JL; Thompson LM; Wanker EE; Young AB; Housman DE; Bates GP; Sherman MY; Kazantsev AG
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):892-7. PubMed ID: 15642944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis.
    Lee YH; Tsai YS; Chang CC; Ho CC; Shih HM; Chen HM; Lai HL; Lee CW; Lee YC; Liao YC; Yang UC; Cheng TH; Chern Y; Soong BW
    Mov Disord; 2022 Apr; 37(4):767-777. PubMed ID: 34951052
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.